Cardax Pharma
Honolulu, US · Founded 2013
Biotech
Founders & leadership
NM
Nicholas MitsakosNamed on SEC filing
DG
David G. WatumullNamed on SEC filing
FC
Frank C. HerringerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 1 round · 2014
▶$2.1MraisedJan 2014 · 26 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedJan 2014 · 26 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas MitsakosDirector
- David G. WatumullExecutive Officer
- Frank C. HerringerDirector
- Offering amount
- $5M
- Amount sold
- $2.1M
- Minimum investment
- $12K
- Sales commissions
- $269.9K
- Proceeds to insiders
- $45K
- Placement agents
- Agincourt Ltd., Portfolio Advisors Alliance, Inc.
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cardax Pharma raised?
- Cardax Pharma has disclosed $2.1M raised across 1 round.
- Where is Cardax Pharma headquartered?
- Cardax Pharma is headquartered in Honolulu, US.